Page last updated: 2024-09-04

thiobenzyl benzyloxycarbonyl-l-lysinate and thapsigargin

thiobenzyl benzyloxycarbonyl-l-lysinate has been researched along with thapsigargin in 1 studies

Compound Research Comparison

Studies
(thiobenzyl benzyloxycarbonyl-l-lysinate)
Trials
(thiobenzyl benzyloxycarbonyl-l-lysinate)
Recent Studies (post-2010)
(thiobenzyl benzyloxycarbonyl-l-lysinate)
Studies
(thapsigargin)
Trials
(thapsigargin)
Recent Studies (post-2010) (thapsigargin)
9005,2343918

Protein Interaction Comparison

ProteinTaxonomythiobenzyl benzyloxycarbonyl-l-lysinate (IC50)thapsigargin (IC50)
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1Oryctolagus cuniculus (rabbit)0.002

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, RA; Pores-Fernando, AT; Wurth, GA; Zweifach, A1

Other Studies

1 other study(ies) available for thiobenzyl benzyloxycarbonyl-l-lysinate and thapsigargin

ArticleYear
Exocytic responses of single leukaemic human cytotoxic T lymphocytes stimulated by agents that bypass the T cell receptor.
    The Journal of physiology, 2005, Sep-15, Volume: 567, Issue:Pt 3

    Topics: Cell Degranulation; Cell Line, Tumor; Flow Cytometry; Granzymes; Humans; Leukemia; Lysine; Lysosomal-Associated Membrane Protein 1; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Receptors, Antigen, T-Cell; Serine Endopeptidases; Stimulation, Chemical; T-Lymphocytes, Cytotoxic; Tetradecanoylphorbol Acetate; Thapsigargin

2005